Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: South Africa Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20051
20061
20073
20083
20093
20101
20112
20121
20131
20141
20161
20202
20212
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Active, not recruiting5
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Sanofi4
Pfizer3
Abbott2
Amgen2
Debiopharm International SA2
Janssen Research & Development, LLC2
Merck Sharp & Dohme LLC2
Aragon Pharmaceuticals, Inc.1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms32
Neoplasms4
Bone Diseases, Metabolic1
Breast Neoplasms1
Cataract1
Neoplasm Metastasis1
Osteoporosis1
Recurrence1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.